多种代谢参数与 GDF15 分泌调节之间的关系研究进展
摘要
关键词
全文:
PDF参考
Bootcov MR, Bauskin AR, Valenzuela SM, et al. MIC-1, a novel macrophage inhibitory cytokine, is a divergent member of the TGF-beta superfamily[J]. Proc Natl Acad Sci U S A. 1997,94(21):11514-11519.
Yang L, Chang CC, Sun Z, et al. GFRAL is the receptor for GDF15 and is required for the anti-obesity effects of the ligand[J]. Nat Med. 2017,23(10):1158-1166.
Reyes J, Yap GS. Emerging Roles of Growth Differentiation Factor 15 in Immunoregulation and Pathogenesis[J]. Immunol, 2023,210(1):5-11.
Wischhusen J, Melero I, Fridman WH. Growth/Differentiation Factor-15 (GDF-15): From Biomarker to Novel Targetable Immune Checkpoint[J]. Front Immunol,2020,11:95.
Eddy AC, Trask AJ. Growth differentiation factor-15 and its role in diabetes and cardiovascular disease[J]. Cytokine Growth Factor Rev, 2021,57:11-18.
Qian X, He S, Shen X, et al. Circulating levels of GDF-15 for predicting cardiovascular and cancer morbidity and mortality in type 2 diabetes: Findings from Da Qing IGT and Diabetes Study[J]. Diabetes Metab, 2022,48(6):101380.
Niu Y, Zhang W, Shi J, et al. The Relationship Between Circulating Growth Differentiation Factor 15 Levels and Diabetic Retinopathy in Patients With Type 2 Diabetes[J]. Front Endocrinol (Lausanne), 2021,12:627395.
Zhang H, Mulya A, Nieuwoudt S, et al. GDF15 Mediates the Effect of Skeletal Muscle Contraction on Glucose-Stimulated Insulin Secretion[J]. Diabetes, 2023,72(8):1070-1082.
Li E, Chen P, Lu J, et al. Serum growth differentiation factor 15 is closely associated with metabolic abnormalities in Chinese pregnant women[J]. Diabetes Investig, 2021,12(8):1501-1507.
Al-Kuraishy HM, Al-Gareeb AI, Alexiou A, et al. Metformin and growth differentiation factor 15 (GDF15) in type 2 diabetes mellitus: A hidden treasure[J]. Diabetes, 2022,14(12):806-814.
Sarkar S, Legere S, Haidl I, et al. Serum GDF15, a Promising Biomarker in Obese Patients Undergoing Heart Surgery[J]. Front Cardiovasc Med, 2020,7:103.
Ho LC, Wu HT, Hung HC, et al. Growth differentiation factor-15 is independently associated with metabolic syndrome and hyperglycemia in non-elderly subjects published correction appears in Biofactors[J]. Sep-Oct, 2023,49(5):1099.
Wang D, Day EA, Townsend LK, et al. GDF15: emerging biology and therapeutic applications for obesity and cardiometabolic disease[J]. Nat Rev Endocrinol, 2021,17(10):592-607.
Klein AB, Nicolaisen TS, Ørtenblad N, et al. Pharmacological but not physiological GDF15 suppresses feeding and the motivation to exercise[J]. Nat Commun, 2021,12(1):1041.
Kleinert M, Clemmensen C, Sjøberg KA, et al. Exercise increases circulating GDF15 in humans[J]. Mol Metab, 2018,9:187-191.
Zhang H, Fealy CE, Kirwan JP. Exercise training promotes a GDF15-associated reduction in fat mass in older adults with obesity[J]. Am J Physiol Endocrinol Metab, 2019,316(5):E829-E836.
Patel S, Alvarez-Guaita A, Melvin A, et al. GDF15 Provides an Endocrine Signal of Nutritional Stress in Mice and Humans[J]. Cell Metab, 2019,29(3):707-718.e8.
Tsai VW, Macia L, Feinle-Bisset C, et al. Serum Levels of Human MIC-1/GDF15 Vary in a Diurnal Pattern, Do Not Display a Profile Suggestive of a Satiety Factor and Are Related to BMI[J]. PLoS One, 2015,10(7):e0133362.
Richter MM, Plomgaard P. The Regulation of Circulating Hepatokines by Fructose Ingestion in Humans[J]. J Endocr Soc, 2021,5(9):bvab121.
Martinussen C, Svane MS, Bojsen-Møller KN, et al. Plasma GDF15 levels are similar between subjects after bariatric surgery and matched controls and are unaffected by meals[J]. Am J Physiol Endocrinol Metab, 2021,321(4):E443-E452.
Thom G, Dombrowski SU, Brosnahan N, et al. Correction to: The role of appetite-related hormones, adaptive thermogenesis, perceived hunger and stress in long-term weight-loss maintenance: a mixed-methods study[J]. Eur J Clin Nutr, 2021,75(6):997-998.
Imbert A, Vialaneix N, Marquis J, et al. Network Analyses Reveal Negative Link Between Changes in Adipose Tissue GDF15 and BMI During Dietary-induced Weight Loss[J]. Clin Endocrinol Metab, 2022,107(1):e130-e142.
Zhao J, Li M, Chen Y, et al. Elevated Serum Growth Differentiation Factor 15 Levels in Hyperthyroid Patients[J]. Front Endocrinol (Lausanne), 2019,9:793.
Arslan D, Buyukinan M, Uysal C, Deniz CD. Evaluation of cardiovascular risk by growth-differentiation factor-15 and tissue Doppler imaging in children with subclinical hypothyroidism[J]. Endocrine, 2019,65(3):601-607.
Westhrin M, Moen SH, Holien T, et al. Growth differentiation factor 15 (GDF15) promotes osteoclast differentiation and inhibits osteoblast differentiation and high serum GDF15 levels are associated with multiple myeloma bone disease[J]. Haematologica, 2015,100(12):e511-e514.
Li W, Li C, Zhou X, Jiang T, Guo L, Liu H. Relationship between GDF15 level and bone metabolism in postmenopausal Chinese women[J]. Gynecol Endocrinol, 2020,36(8):714-717.
Osawa Y, Tanaka T, Semba RD, et al. Plasma Growth and Differentiation Factor 15 Predict Longitudinal Changes in Bone Parameters in Women, but Not in Men[J]. Gerontol A Biol Sci Med Sci, 2022,77(10):1951-1958.
DOI: http://dx.doi.org/10.12345/yzlcyxzz.v7i11.22429
Refbacks
- 当前没有refback。
此作品已接受知识共享署名-非商业性使用 4.0国际许可协议的许可。